Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis

Prostate cancer (PCa) is the most common cancer in men worldwide. The current gold standard for diagnosing PCa relies on a transrectal ultrasound-guided systematic core needle biopsy indicated after detection changes in a digital rectal examination (DRE) and elevated prostate-specific antigen (PSA)...

Full description

Bibliographic Details
Main Authors: Milena Matuszczak, Jack A. Schalken, Maciej Salagierski
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
cancer biomarkers
prostate cancer
liquid biopsy
prognosis
diagnosis
early detection
Online Access:https://www.mdpi.com/2072-6694/13/13/3373

Similar Items

Similar Items